Session

JAK-ING UP THE BAR: “Can targeted inhibition of JAK/STAT signalling improve patient outcomes?” (AbbVie)

JAK-ING UP THE BAR: “Can targeted inhibition of JAK/STAT signalling improve patient outcomes (AbbVie)
JAK-ING UP THE BAR: “Can targeted inhibition of JAK/STAT signalling improve patient outcomes (AbbVie)

JAK-ING UP THE BAR: “Can targeted inhibition of JAK/STAT signalling improve patient outcomes?” (AbbVie)  et al.

Item 1 - 1 / 1
1